|
|
|
|
|
|
|
|
Timetable
|
|
FRIDAY, MAY 25, 2012 |
|
|
N. N. Anitschkow Hall |
T. Miettinen Hall |
S.O. Olofsson Hall |
|
09:00 |
Registration Desk Opens |
|
14:00-15:30 |
|
General Assembly
EAS Members Only
|
|
| 16:00-17:30 |
|
|
Educational Symposium : In focus: translating HDL raising into potential clinical benefit – emerging evidence |
|
18:00-20:00 |
Opening Ceremony, including the Anitschkow Lecture
Followed by a Welcome Reception |
|
SATURDAY, MAY 26, 2012 |
|
|
N. N. Anitschkow Hall |
T. Miettinen Hall |
S.O. Olofsson Hall |
P. Avogaro Hall |
|
08:30-10:30 |
Plenary Session: Cellular and humoral factors in the arterial wall determine the course of atherogenesis and vascular function |
|
|
|
|
10:30–11:00 |
Coffee break and Exhibition |
|
11:00–12:30 |
Workshop:
Innate and adaptive immunity in atherosclerosis |
Workshop:
Intestinal flora as regulator of lipid metabolism |
Workshop:
Genetic and genomic approaches for identifying new risk factors and therapeutic targets |
Workshop:
New molecular targets for drugs in the treatment of dyslipidemia
|
|
12:30-15:00 |
Poster Presentations
13:50 – 14:50 Moderated Poster Session A |
|
|
|
12:40 – 14:10
STRATEGIES FOR COMPREHENSIVE LIPID MANAGEMENT IN HIGH RISK PATIENTS
EBAC-Accredited Educational Programme, supported by an unrestricted educational grant from AstraZeneca |
12:45 - 13:30 The impact of off-patent medicines on cardiovascular care: the case of statins
Special Session Sponsored by Pfizer through a partial grant |
|
|
|
|
14:10 – 15:00
NUTRACEUTICALS FOR CARDIOVASCULAR PREVENTION: BRIDGING THE GAP BETWEEN LIFESTYLE THERAPEUTICAL
Workshop sponsored by Rottapharm | Madaus |
|
|
15:00-16:30 |
Workshop: Bioactive compounds and inflammation in the arterial wall |
Workshop: HDL: New mechanisms involved in their atheroprotective role |
15:00 – 15:40
Meet the Expert |
15:00 – 16:30
Late-Breaking Session |
|
15:45 – 16:30
How To… Session |
|
|
16:30-17:00 |
Coffee break and Exhibition |
|
17:00-18:30 |
|
CLINICAL CONSIDERATIONS AND PRACTICAL APPROACHES TO MANAGING PATIENTS WITH DYSLIPIDEMIA
Educational Symposium sponsored by MSD |
SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA AND THE POTENTIAL ROLE OF ANTISENSE TECHNOLOGY
Educational Symposium sponsored by Genzyme
|
|
| SUNDAY, MAY 27, 2012 |
|
|
N. N. Anitschkow Hall |
T. Miettinen Hall |
S.O. Olofsson Hall |
P. Avogaro Hall |
|
08:30-10:30 |
Plenary Session: Lipoproteins and atherogenesis: New insights |
|
|
|
|
10:30-11:00 |
Coffee break and Exhibition |
|
11:00-12:30 |
Workshop:
Role of macrophages in atherogenesis |
Workshop: Joint ICCR/EAS : Adipose tissue: from dysfunction to metabolic diseases
|
Workshop: Risk factors of cardiovascular diseases: a changing landscape |
Workshop: How should a healthy diet look like -any need for supplements?
|
|
12:30-15:00 |
Poster Presentations
12:40 – 13:40 Moderated Poster Session B
13:50 – 14:50 Moderated Poster Session C |
|
|
|
|
12:40-14:10 NEW THERAPEUTIC APPROACHES FOR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Educational Symposium sponsored by Aegerion |
|
|
|
|
14:10-14:55 PCSK9 – a new target for reducing LDL Cholesterol - Special Lecture sponsored by Sanofi\Regeneron |
|
15:00-16:30
|
Workshop: Biomarkers, from association to a causative role |
Workshop:
Familial dyslipidemias: detection and therapy |
15.00-15.40
Debate |
15.45-16.30
Meet the Expert |
15:00 – 15:45
USE OF INFUSED HDL TO TREAT ACUTE CORONARY SYNDROME
Special Lecture sponsored by CSL Behring |
|
15:45-16:30
EAS YOUNG INVESTIGATOR AWARD-WINNERS SESSION |
|
16:30-17:00 |
Coffee break and Exhibition - Sponsored by KOWA |
|
17:00-18:30 |
|
PITAVASTATIN: NEW EFFECTIVE OPTION FOR MANAGING DYSLIPIDAEMIA WITH DIABETES OR HIGH CARDIOVASCULAR RISK
Educational Symposium sponsored by KOWA |
17:00 – 17:45
CETP INHIBITION WITH ANACETRAPIB - IMPACT ON ATHEROGENIC LIPOPROTEINS
Special Lecture sponsored by MSD |
|
| MONDAY, MAY 28, 2012 |
|
|
N. N. Anitschkow Hall |
T. Miettinen Hall |
S.O. Olofsson Hall |
P. Avogaro Hall |
|
08:30-10:30 |
|
Plenary Session: Cardiovascular treatment: Whom to treat, how to treat, and at what cost?
|
|
|
|
10:30-11:00 |
Coffee break and Exhibition |
|
11:00-12:30 |
Workshop: Cellular trafficking in arteries and atherosclerosis |
Workshop: Plasma lipoprotein metabolism and atherosclerosis |
Workshop: Joint ESC/EAS Session on the Joint Cardiovascular Disease Prevention Guidelines |
New therapeutic strategies for controlling production and catabolism of apolipoprotein B-100- containing lipoproteins | |
|
|
|
|